2018
DOI: 10.1007/s42452-018-0043-6
|View full text |Cite
|
Sign up to set email alerts
|

Emission features, surface morphology and optical limiting properties of semiconducting Toluidine Blue O dye-poly(vinyl alcohol) nanocomposite architecture

Abstract: Fabrication of a new nanocomposite architecture comprising small weight percentage (< 0.5 wt%) of Toluidine Blue O dye as a filler in host polymer poly(vinyl alcohol) (PVA) via a simple route based on solution-casting is presented. Their microstructure, electrical, linear optical and third-order nonlinear optical properties are introduced here. These samples were characterized as nanocomposites, with dye chromophore uniformly distributed in the molecular chains of the polymer PVA. The effect of fluorescence qu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…1) is a thiazine dye discovered by William Henry Perkin in 1856. TBO is widely used in photodynamic therapy of bacterial infections [1-8], for staining tissues and cells [9][10][11], as well as in biosensors (together with nanostructures) [12][13][14][15][16], solar cells [17] and semiconductor nanocomposites [18]. The therapy of Alzheimer's disease with TBO based on its inhibition of Tau protein aggregation is promising [19].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1) is a thiazine dye discovered by William Henry Perkin in 1856. TBO is widely used in photodynamic therapy of bacterial infections [1-8], for staining tissues and cells [9][10][11], as well as in biosensors (together with nanostructures) [12][13][14][15][16], solar cells [17] and semiconductor nanocomposites [18]. The therapy of Alzheimer's disease with TBO based on its inhibition of Tau protein aggregation is promising [19].…”
Section: Introductionmentioning
confidence: 99%
“…The therapy of Alzheimer's disease with TBO based on its inhibition of Tau protein aggregation is promising [19]. Using optical methods, it was found that the TBO molecule is able to effectively bind to DNA [20][21][22][23][24][25][26], RNA [26][27][28], proteins [19,[29][30][31][32][33][34], silver nanoparticles [6,35,36], silica [15] and cadmium sulfide [37], natural organic matter [38], cyclodextrins [39][40][41], surfactant micelles [40][41][42], chitosan [43], heparin [44], nanotubes [2], fatty acids [45] , polysaccharides [9,[46][47][48] and other polymers [18,49,50]. Numerous experimental optical studies of TBO itself have been carried outaggregation [21,[51][52][53][54], reduction [36,42,[55]…”
Section: Introductionmentioning
confidence: 99%
“…Fe, Al, Au, Cu, and Ag), oxides of metal (NiO, Al 2 O 3 , SiO 2 , PbO 2 , and Fe 2 O 3 ), different nanoparticles (e.g. NaI, CO, HgS, and NaI), semiconductors, carbon nanotubes, and magnetic nanoparticles have been utilized as an additive material in the polymer matrix to enhance its properties [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26]. Polyvinyl alcohol (PVA) is the most applicable host material for different nanoparticles with its unique physical features represented in high transmittance, non-corrosive nature, chemical resistance, thermostability, high mechanical strength, and easy processability, and high surface area [27][28][29][30].…”
mentioning
confidence: 99%